This study aimed to investigate whether the FROC diffusion model could help predict molecular biomarkers in gliomas. It was found that FROC has the potential in comprehensively characterizing heterogeneity of gliomas, not only in glioma grading, but also in predicting tumor cell proliferation rate and isocitrate dehydrogenase-1 (IDH-1) gene mutation status.
This abstract and the presentation materials are available to members only; a login is required.